Breathing Parameter Measurements for Lung Deposition Simulation - Trial NCT05445349
Access comprehensive clinical trial information for NCT05445349 through Pure Global AI's free database. This phase not specified trial is sponsored by Medisol Development Kft. and is currently Not yet recruiting. The study focuses on Asthma,COPD. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Emptied dry powder inhalers (DPI) used in routine asthma and COPD therapy
Observational
device
Sponsor & Location
Medisol Development Kft.
Timeline & Enrollment
N/A
Aug 01, 2022
Jun 30, 2025
Primary Outcome
Lung deposition fraction
Summary
This study aims to simulate the deposition of aerosol drugs within the airways of asthma and
 COPD patients based on realistic breathing patterns measured at different pulmonology
 centers.
 
 Further goal of the study is to find correlations between the amount of drug depositing in
 the lungs and the measured breathing parameters, as well as disease status and demographic
 data. The results of the study will be part of a major objective targeting the optimization
 and personalization of aerosol drug therapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05445349
Device Trial